Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06626_nanopub.RAzkOW3UoRxdZTmqIZKUe5IBLY7iLIENvm0XcI0vrxjco#assertion>. }
Showing items 1 to 21 of
21
with 100 items per page.
- drugbank:DB06626 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06626 label "Axitinib [drugbank:DB06626]" assertion.
- drugbank:DB06626 seeAlso DB06626 assertion.
- drugbank:DB06626 seeAlso axitinib.html assertion.
- drugbank:DB06626 seeAlso inlyta-drug.htm assertion.
- drugbank:DB06626 identifier "drugbank:DB06626" assertion.
- drugbank:DB06626 description "Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3. Axitinib is marketed under the name Inlyta®, and if one previous systemic therapy for kidney cell cancer has failed, axitinib is indicated." assertion.
- drugbank:DB06626 title "Axitinib" assertion.
- drugbank:DB06626 bio2rdf_vocabulary:identifier "DB06626" assertion.
- drugbank:DB06626 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06626 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06626" assertion.
- drugbank:DB06626 bio2rdf_vocabulary:x-identifiers.org DB06626 assertion.
- drugbank:DB06626 drugbank_vocabulary:drugbank-id "DB06626" assertion.
- drugbank:DB06626 drugbank_vocabulary:x-cas cas:319460-85-0 assertion.
- drugbank:DB06626 drugbank_vocabulary:x-ahfs ahfs:10:00 assertion.
- drugbank:DB06626 drugbank_vocabulary:x-atc atc:L01XE17 assertion.
- drugbank:DB06626 drugbank_vocabulary:x-chebi chebi:66910 assertion.
- drugbank:DB06626 drugbank_vocabulary:x-kegg kegg:D03218 assertion.
- drugbank:DB06626 drugbank_vocabulary:x-pharmgkb pharmgkb:PA164924493 assertion.
- drugbank:DB06626 drugbank_vocabulary:x-wikipedia wikipedia:Axitinib assertion.
- drugbank:DB06626 drugbank_vocabulary:x-ndc ndc:0069-0145-01 assertion.